-+ 0.00%
-+ 0.00%
-+ 0.00%

Corcept Therapeutics Reports Q2 2025 Revenue Increase to $194.4M, Net Income Slightly Declines to $35.1M, EPS at $0.29

Reuters·07/31/2025 20:08:53

Please log in to view news